Bio News
Cuts pathology interpretation time from 20 minutes to 5 minutes; AI model records 94% accuracy Detects microscopic residual cancer cells in real time during surgery, demonstrating clinical value
Vpix Medical’s real-time cancer diagnosis solution, ‘cCeLL,’ recorded 94% accuracy in AI diagnosis and cut pathology interpretation time fourfold to within 5 minutes. In a multicenter clinical study, the AI model demonstrated its value by detecting microscopic residual cancer in real time during surgery. The company plans to pursue regulatory approval for the AI model and move forward with global commercialization.
BIOBOOK TEAM
biobookmedia@biobook.co.krMerck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
RDA develops technology to produce anti-inflammatory exosomes for pets and files patent application
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
